Does MONTELUKAST Cause Hyperlipidaemia? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Hyperlipidaemia have been filed in association with MONTELUKAST (Montelukast). This represents 0.2% of all adverse event reports for MONTELUKAST.
63
Reports of Hyperlipidaemia with MONTELUKAST
0.2%
of all MONTELUKAST reports
11
Deaths
57
Hospitalizations
How Dangerous Is Hyperlipidaemia From MONTELUKAST?
Of the 63 reports, 11 (17.5%) resulted in death, 57 (90.5%) required hospitalization, and 11 (17.5%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which MONTELUKAST Alternatives Have Lower Hyperlipidaemia Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE